Latest Insider Transactions at Catalyst Pharmaceuticals, Inc. (CPRX)
This section provides a real-time view of insider transactions for Catalyst Pharmaceuticals, Inc. (CPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CATALYST PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CATALYST PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 03
2021
|
Patrick J Mcenany Director |
SELL
Payment of exercise price or tax liability
|
Direct |
12,132
-0.25%
|
-
|
Dec 03
2021
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,833
+0.62%
|
-
|
Aug 26
2021
|
Philip H Coelho Director |
SELL
Open market or private sale
|
Direct |
9,548
-1.93%
|
$47,740
$5.46 P/Share
|
Aug 26
2021
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+6.3%
|
$49,998
$3.12 P/Share
|
Aug 25
2021
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
80,000
-9.74%
|
$400,000
$5.56 P/Share
|
Aug 25
2021
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
120,000
+12.74%
|
$360,000
$3.12 P/Share
|
Aug 25
2021
|
Philip H Coelho Director |
SELL
Open market or private sale
|
Direct |
9,498
-3.95%
|
$47,490
$5.56 P/Share
|
Aug 25
2021
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+6.48%
|
$50,001
$3.12 P/Share
|
Aug 24
2021
|
Philip H Coelho Director |
SELL
Open market or private sale
|
Direct |
9,494
-4.07%
|
$47,470
$5.58 P/Share
|
Aug 24
2021
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+6.66%
|
$50,001
$3.12 P/Share
|
Aug 23
2021
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
82,617
-1.65%
|
$413,085
$5.62 P/Share
|
Aug 23
2021
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
120,000
+2.35%
|
$360,000
$3.12 P/Share
|
Aug 20
2021
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
54,161
-1.1%
|
$270,805
$5.52 P/Share
|
Aug 20
2021
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+1.6%
|
$240,000
$3.12 P/Share
|
Aug 18
2021
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
13,000
-2.72%
|
$65,000
$5.68 P/Share
|
Aug 18
2021
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+12.79%
|
$210,000
$3.12 P/Share
|
Aug 17
2021
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
100,000
-19.71%
|
$500,000
$5.67 P/Share
|
Aug 17
2021
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+16.46%
|
$300,000
$3.12 P/Share
|
Aug 16
2021
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.56%
|
$150,000
$3.12 P/Share
|
Aug 13
2021
|
David S Tierney Director |
SELL
Open market or private sale
|
Direct |
50,000
-14.01%
|
$300,000
$6.08 P/Share
|
Aug 13
2021
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+12.29%
|
$150,000
$3.12 P/Share
|
Aug 13
2021
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
40,963
-5.52%
|
$245,778
$6.09 P/Share
|
Aug 13
2021
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
65,000
+8.05%
|
$195,000
$3.12 P/Share
|
Aug 13
2021
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
62,715
-0.64%
|
$376,290
$6.12 P/Share
|
Aug 13
2021
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+2.0%
|
$300,000
$3.12 P/Share
|
Jun 24
2021
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,930
-29.3%
|
-
|
Jun 24
2021
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
-
|
Dec 22
2020
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+50.0%
|
-
|
Dec 22
2020
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.87%
|
-
|
Dec 22
2020
|
Patrick J Mcenany Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,507
-0.16%
|
-
|
Dec 22
2020
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,833
+0.64%
|
-
|
Dec 22
2020
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
3,668
-25.01%
|
$11,004
$3.45 P/Share
|
Dec 22
2020
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,666
+50.0%
|
-
|
Dec 22
2020
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.61%
|
-
|
Dec 22
2020
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.24%
|
-
|
Dec 22
2020
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.43%
|
-
|
Dec 22
2020
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,666
+50.0%
|
-
|
Dec 22
2020
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.59%
|
-
|
Dec 22
2020
|
Alicia Grande VP, Treasurer and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,571
-0.87%
|
-
|
Dec 22
2020
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,666
+3.45%
|
-
|
Sep 30
2020
|
Patrick J Mcenany Director |
BUY
Open market or private purchase
|
Direct |
15,000
+0.31%
|
$30,000
$2.97 P/Share
|
Sep 30
2020
|
Charles B O'Keeffe Director |
BUY
Open market or private purchase
|
Direct |
7,000
+1.23%
|
$14,000
$2.99 P/Share
|